Evidence map›Paper›PMID 35160116›Full record

ArticleJournal of clinical medicine2022

The Significance of the Alter miR let-7a and miR-335 Expression Level Regulating the CCR7/CCL19 Axis as Potential Biomarkers of Tumor Progression in NSCLC.

Kamila Baran, Jacek Kordiak, Sławomir Jabłoński, Adam Antczak, Ewa Brzeziańska-Lasota

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Liquid Biopsy and Cancer: An Ongoing Story.Journal of clinical medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kamila BaranDepartment of Biomedicine and Genetics, Medical University of Lodz, 92-213 Lodz, Poland.ORCID 0000-0002-0029-9706
Jacek KordiakDepartment of Thoracic, General and Oncological Surgery, Medical University of Lodz, 90-549 Lodz, Poland.
Sławomir JabłońskiDepartment of Thoracic, General and Oncological Surgery, Medical University of Lodz, 90-549 Lodz, Poland.
Adam AntczakDepartment of General and Oncological Pulmonology, Medical University of Lodz, 90-153 Lodz, Poland.
Ewa Brzeziańska-LasotaDepartment of Biomedicine and Genetics, Medical University of Lodz, 92-213 Lodz, Poland.ORCID 0000-0002-0882-1458
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chemokine receptor 7/C-C ligand 19 chemokine (CCR7/CCL19) has been implicated in the development and progression of NSCLC. Its expression is regulated by various epigenetic factors including miRNAs. The aim of this study was to assess the expression of

Indexed as

CCL19CCR7miR-335miR let-7anon-small lung cancerreal-time polymerase chain reaction

Identifiers

PMID35160116
PMCPMC8836798
OpenAlexW4210710894

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.